You are here
Home > Business > Health Care > Share Analysis of Next Generation Sequencing Market Research Study

Share Analysis of Next Generation Sequencing Market Research Study

Latest Report Available at Orbis research Next Generation Sequencing Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

Request sample copy of this report at Next Generation Sequencing Market Research Report

In this report, the EMEA Next Generation Sequencing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Next Generation Sequencing for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Next Generation Sequencing market competition by top manufacturers/players, with Next Generation Sequencing sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar

Purchase a copy of Next Generation Sequencing Market visit @  http://www.orbisresearch.com/contact/purchase/352720  For more information contact [email protected]   

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Next Generation Sequencing for each application, including
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others

 Browse Complete Report @ http://www.orbisresearch.com/reports/index/emea-europe-middle-east-and-africa-next-generation-sequencing-market-report-2017 .

 Some points From TOC:

Chapter One: Next Generation Sequencing Overview
1.1 Product Overview and Scope of Next Generation Sequencing
1.2 Classification of Next Generation Sequencing
1.2.1 EMEA Next Generation Sequencing Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Next Generation Sequencing Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Targeted Sequencing & Resequencing
1.2.4 Whole Genome Sequencing
1.2.5 Whole Exome Sequencing
1.3 EMEA Next Generation Sequencing Market by Application/End Users
1.3.1 EMEA Next Generation Sequencing Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Whole-genome Sequencing
1.3.3 Exome Sequencing
1.3.4 Targeted Resequencing
1.3.5 De Novo Sequencing
1.3.6 RNA Sequencing
1.3.7 ChIP Sequencing
1.3.8 Methyl Sequencing
1.3.9 Others
1.4 EMEA Next Generation Sequencing Market by Region
1.4.1 EMEA Next Generation Sequencing Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Next Generation Sequencing (2012-2022)
1.5.1 EMEA Next Generation Sequencing Sales and Growth Rate (2012-2022)
1.5.2 EMEA Next Generation Sequencing Revenue and Growth Rate (2012-2022)

Chapter Two: EMEA Next Generation Sequencing Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Next Generation Sequencing Market Competition by Players/Manufacturers
2.1.1 EMEA Next Generation Sequencing Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Next Generation Sequencing Revenue and Share by Players (2012-2017)
2.1.3 EMEA Next Generation Sequencing Sale Price by Players (2012-2017)
2.2 EMEA Next Generation Sequencing (Volume and Value) by Type/Product Category
2.2.1 EMEA Next Generation Sequencing Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Next Generation Sequencing Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Next Generation Sequencing Sale Price by Type (2012-2017)
2.3 EMEA Next Generation Sequencing (Volume) by Application
2.4 EMEA Next Generation Sequencing (Volume and Value) by Region
2.4.1 EMEA Next Generation Sequencing Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Next Generation Sequencing Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Next Generation Sequencing Sales Price by Region (2012-2017)

 For any enquires before buying, connect with us @ [email protected]

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115

Leave a Reply

Top